Literature DB >> 22579148

A case of akathisia after switching from branded to generic high-dose olanzapine.

Joseph F Goldberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22579148     DOI： 10.4088/JCP.11cr07606

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  4 in total

1.  Optimal sampling of antipsychotic medicines: a pharmacometric approach for clinical practice.

Authors:  Vidya Perera; Robert R Bies; Gary Mo; Michael J Dolton; Vaughan J Carr; Andrew J McLachlan; Richard O Day; Thomas M Polasek; Alan Forrest
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

Review 2.  Rational use of generic psychotropic drugs.

Authors:  Maren Carbon; Christoph U Correll
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

3.  Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands.

Authors:  Pieter J Glerum; Marc Maliepaard; Vincent de Valk; Joep H G Scholl; Florence P A M van Hunsel; Eugène P van Puijenbroek; David M Burger; Kees Neef
Journal:  Clin Transl Sci       Date:  2020-02-12       Impact factor: 4.689

4.  Mental state deterioration after switching from brand-name to generic olanzapine in an adolescent with bipolar affective disorder, autism and intellectual disability: a case study.

Authors:  Rani Samuel; Azizah Attard; Marinos Kyriakopoulos
Journal:  BMC Psychiatry       Date:  2013-10-04       Impact factor: 3.630
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.